PF-06473871

DRUG2 trials

Sponsors

Pfizer

Conditions

Hypertrophic Scars Resulting From Prior Breast Scar Revision SurgeryReduction of Hypertrophic Skin Scarring

Phase 2

Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery

CompletedNCT01730339

PfizerReduction of Hypertrophic Skin Scarring

Start: 2012-12-31End: 2014-10-31Updated: 2016-02-17

A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study

TerminatedNCT02205476

PfizerHypertrophic Scars Resulting From Prior Breast Scar Revision Surgery

Start: 2014-12-31End: 2015-01-31Updated: 2016-01-28